Conestoga Capital Advisors, LLC - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 63 filers reported holding IRADIMED CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Conestoga Capital Advisors, LLC ownership history of IRADIMED CORP
ValueSharesWeighting
Q4 2016$5,601,000
-42.5%
504,600
-11.9%
0.37%
-44.1%
Q3 2016$9,733,000
+55.4%
572,885
+99.0%
0.67%
+44.1%
Q2 2016$6,263,000
+1.8%
287,835
-10.3%
0.46%
+11.3%
Q1 2016$6,151,000
+57.0%
321,010
+129.6%
0.42%
+31.2%
Q4 2015$3,919,000139,8050.32%
Other shareholders
IRADIMED CORP shareholders Q3 2016
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 771,311$34,223,00010.44%
RK Capital 300,800$13,346,4963.16%
Soleus Capital Management, L.P. 628,206$27,873,5002.57%
Ballast Asset Management, LP 25,088$1,113,1551.03%
Bridge City Capital, LLC 28,172$1,249,9920.63%
Ranger Investment Management 212,147$9,412,9620.62%
Bares Capital Management 277,000$12,290,4900.52%
Riverwater Partners LLC 11,636$516,2890.47%
Hillsdale Investment Management Inc. 90,010$3,993,7440.37%
SHAKER INVESTMENTS LLC/OH 12,919$573,2160.32%
View complete list of IRADIMED CORP shareholders